Academic Journals Database
Disseminating quality controlled scientific knowledge

Cancers

ISSN: 2072--6694
Publisher: Molecular Diversity Preservation International


ADD TO MY LIST
 
Circulating Tumor Cells in Prostate Cancer

Author(s): Brian Hu | Holly Rochefort | Amir Goldkorn
Volume: 5
Issue: 4
Year: 2013
Long Non-Coding RNAs Embedded in the Rb and p53 Pathways

Author(s): Murugan Subramanian | Matthew F. Jones | Ashish Lal
Volume: 5
Issue: 4
Year: 2013
Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis

Author(s): Ana M.C. Barradas | Leon W.M.M. Terstappen
Volume: 5
Issue: 4
Year: 2013
Role of Met Axis in Head and Neck Cancer

Author(s): Yiru Xu | Gary J. Fisher
Volume: 5
Issue: 4
Year: 2013
Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma

Author(s): Antje M. Richter | Tanja Haag | Sara Walesch | Peter Herrmann-Trost | Wolfgang C. Marsch | Heinz Kutzner | Peter Helmbold | Reinhard H. Dammann
Volume: 5
Issue: 4
Year: 2013
Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells

Author(s): Monica Charpentier | Stuart Martin
Volume: 5
Issue: 4
Year: 2013
Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle

Author(s): Carolina Soekmadji | Pamela J. Russell | Colleen C. Nelson
Volume: 5
Issue: 4
Year: 2013
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment

Author(s): Santosh Kumar Upadhyay | Alissa Verone | Suzanne Shoemaker | Maochun Qin | Song Liu | Moray Campbell | Pamela A. Hershberger
Volume: 5
Issue: 4
Year: 2013
Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer

Author(s): Aleksandra Markiewicz | Magdalena Książkiewicz | Barbara Seroczyńska | Jarosław Skokowski | Jolanta Szade | Marzena Wełnicka-Jaśkiewicz | Anna J. Zaczek
Volume: 5
Issue: 4
Year: 2013
Tumor Metabolism of Malignant Gliomas

Author(s): Peng Ru | Terence M. Williams | Arnab Chakravarti | Deliang Guo
Volume: 5
Issue: 4
Year: 2013
Bevacizumab for Glioblastoma—A Promising Drug or Not?

Author(s): Motoo Nagane | Ryo Nishikawa
Volume: 5
Issue: 4
Year: 2013
The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation

Author(s): Trude E. Robsahm | Gary G. Schwartz | Steinar Tretli
Volume: 5
Issue: 4
Year: 2013
The Protective Role of Vitamin D Signaling in Non-Melanoma Skin Cancer

Author(s): Daniel D. Bikle | Yan Jiang
Volume: 5
Issue: 4
Year: 2013
Investigation of siRNA Nanoparticle Formation Using Mono-Cationic Detergents and Its Use in Gene Silencing in Human HeLa Cells

Author(s): Yuma Yamada | Ryosuke Suzuki | Hideyoshi Harashima
Volume: 5
Issue: 4
Year: 2013
Immune-Checkpoint Blockade and Active Immunotherapy for Glioma

Author(s): Brian J. Ahn | Ian F. Pollack | Hideho Okada
Volume: 5
Issue: 4
Year: 2013
Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells

Author(s): Magdalena Milczarek | Michał Chodyński | Beata Filip-Psurska | Agnieszka Martowicz | Małgorzata Krupa | Krzysztof Krajewski | Andrzej Kutner | Joanna Wietrzyk
Volume: 5
Issue: 4
Year: 2013
Oxidative Stress in the Carcinogenicity of Chemical Carcinogens

Author(s): Anna Kakehashi | Min Wei | Shoji Fukushima | Hideki Wanibuchi
Volume: 5
Issue: 4
Year: 2013
MicroRNA in Human Glioma

Author(s): Mengfeng Li | Jun Li | Lei Liu | Wei Li | Yi Yang | Jie Yuan
Volume: 5
Issue: 4
Year: 2013
Strategies in Gene Therapy for Glioblastoma

Author(s): Aneta Kwiatkowska | Mohan S. Nandhu | Prajna Behera | E. Antonio Chiocca | Mariano S. Viapiano
Volume: 5
Issue: 4
Year: 2013
Gene Regulatory Scenarios of Primary 1,25-Dihydroxyvitamin D3 Target Genes in a Human Myeloid Leukemia Cell Line

Author(s): Jussi Ryynänen | Sabine Seuter | Moray J. Campbell | Carsten Carlberg
Volume: 5
Issue: 4
Year: 2013
Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients via RT-qPCR

Author(s): Ulrich Andergassen | Alexandra C. Kölbl | Stefan Hutter | Klaus Friese | Udo Jeschke
Volume: 5
Issue: 4
Year: 2013
Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer

Author(s): Jo A. Tucker | Caroline Jochems | James L. Gulley | Jeffrey Schlom | Kwong Y. Tsang
Volume: 4
Issue: 4
Year: 2012
Azithromycin Synergistically Enhances Anti-Proliferative Activity of Vincristine in Cervical and Gastric Cancer Cells

Author(s): Xuezhang Zhou | Yuyan Zhang | Yong Li | Xiujing Hao | Xiaoming Liu | Yujiong Wang
Volume: 4
Issue: 4
Year: 2012
Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability

Author(s): Kim M. Boerkamp | Gerard R. Rutteman | Marja J. L. Kik | Jolle Kirpensteijn | Christoph Schulze | Guy C. M. Grinwis
Volume: 4
Issue: 4
Year: 2012
Cancer Cachexia: Muscle Physiology and Exercise Training

Author(s): Claudio L. Battaglini | Anthony C. Hackney | Matthew L. Goodwin
Volume: 4
Issue: 4
Year: 2012
Emerging Roles of ADAMTSs in Angiogenesis and Cancer

Author(s): Saran Kumar | Nithya Rao | Ruowen Ge
Volume: 4
Issue: 4
Year: 2012
dNTP Supply Gene Expression Patterns after P53 Loss

Author(s): Tomas Radivoyevitch | Yogen Saunthararajah | John Pink | Gina Ferris | Ian Lent | Mark Jackson | Damian Junk | Charles A. Kunos
Volume: 4
Issue: 4
Year: 2012
Annotating Cancer Variants and Anti-Cancer Therapeutics in Reactome

Author(s): Marija Milacic | Robin Haw | Karen Rothfels | Guanming Wu | David Croft | Henning Hermjakob | Peter D'Eustachio | Lincoln Stein
Volume: 4
Issue: 4
Year: 2012
The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)

Author(s): Sarit Assouline | Eftihia Cocolakis | Katherine L. B. Borden
Volume: 4
Issue: 4
Year: 2012
Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction

Author(s): Rakhshanda Layeequr Rahman | Sandhya Pruthi
Volume: 4
Issue: 4
Year: 2012
RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis

Author(s): Mark Sutherland | Andrew Gordon | Steven D. Shnyder | Laurence H. Patterson | Helen M. Sheldrake
Volume: 4
Issue: 4
Year: 2012
High Resolution Fluorescence Imaging of Cancers Using Lanthanide Ion-Doped Upconverting Nanocrystals

Author(s): Rafik Naccache | Emma Martín Rodríguez | Nicoleta Bogdan | Francisco Sanz-Rodríguez | Maria del Carmen Iglesias de la Cruz | Ángeles Juarranz de la Fuente | Fiorenzo Vetrone | Daniel Jaque | José García Solé | John A. Capobianco
Volume: 4
Issue: 4
Year: 2012
Do Non-Genomically Encoded Fusion Transcripts Cause Recurrent Chromosomal Translocations?

Author(s): Eric Kowarz | Theo Dingermann | Rolf Marschalek
Volume: 4
Issue: 4
Year: 2012
Mouse Lymphoblastic Leukemias Induced by Aberrant Prdm14 Expression Demonstrate Widespread Copy Number Alterations Also Found in Human ALL

Author(s): Stephen J. Simko | Horatiu Voicu | Brandi L. Carofino | Monica J. Justice
Volume: 4
Issue: 4
Year: 2012
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors

Author(s): Sanne Hindriksen | Maarten F. Bijlsma
Volume: 4
Issue: 4
Year: 2012
Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy

Author(s): Christina S. Baik | Keith D. Eaton
Volume: 4
Issue: 4
Year: 2012
DNA Methylation and the HOXC6 Paradox in Prostate Cancer

Author(s): Anna Vinarskaja | Masanori Yamanaka | Marc Ingenwerth | Wolfgang A. Schulz
Volume: 3
Issue: 4
Year: 2011
Infiltration of M2 Tumor-Associated Macrophages in Oral Squamous Cell Carcinoma Correlates with Tumor Malignancy

Author(s): Kazumasa Mori | Miki Hiroi | Jun Shimada | Yoshihiro Ohmori
Volume: 3
Issue: 4
Year: 2011
Tumor-Associated Macrophages as Incessant Builders and Destroyers of the Cancer Stroma

Author(s): Manuela Liguori | Graziella Solinas | Giovanni Germano | Alberto Mantovani | Paola Allavena
Volume: 3
Issue: 4
Year: 2011
Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice

Author(s): Xi Zheng | Xiao-Xing Cui | Tin Oo Khor | Ying Huang | Robert S DiPaola | Susan Goodin | Mao-Jung Lee | Chung S Yang | Ah-Ng Kong | Allan H. Conney
Volume: 3
Issue: 4
Year: 2011
Biomarkers in Prostate Cancer Epidemiology

Author(s): Mukesh Verma | Payal Patel | Mudit Verma
Volume: 3
Issue: 4
Year: 2011
Combined Hyperthermia and Radiotherapy for the Treatment of Cancer

Author(s): Punit Kaur | Mark D. Hurwitz | Sunil Krishnan | Alexzander Asea
Volume: 3
Issue: 4
Year: 2011
The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer

Author(s): Simon N.S. Louis | Laurie T.C. Chow | Naghmeh Varghayee | Linda A. Rezmann | Albert G. Frauman | William J. Louis
Volume: 3
Issue: 4
Year: 2011
Targeted Radionuclide Therapy

Author(s): Devrim Ersahin | Indukala Doddamane | David Cheng
Volume: 3
Issue: 4
Year: 2011
Cytokines in Cancer Immunotherapy

Author(s): Sylvia Lee | Kim Margolin
Volume: 3
Issue: 4
Year: 2011
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer

Author(s): Dingzhi Wang | Dianren Xia | Raymond N. DuBois
Volume: 3
Issue: 4
Year: 2011
Forced Expression of ZNF143 Restrains Cancer Cell Growth

Author(s): Hiroto Izumi | Yoshihiro Yasuniwa | Masaki Akiyama | Takahiro Yamaguchi | Akihiro Kuma | Noriaki Kitamura | Kimitoshi Kohno
Volume: 3
Issue: 4
Year: 2011
Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells

Author(s): Aisha Sethi | Lynette M. Sholl
Volume: 3
Issue: 4
Year: 2011
Helical Tomotherapy in Children and Adolescents: Dosimetric Comparisons, Opportunities and Issues

Author(s): Maurizio Mascarin | Francesca Maria Giugliano | Elisa Coassin | Annalisa Drigo | Paola Chiovati | Andrea Dassie | Giovanni Franchin | Emilio Minatel | Mauro Gaetano Trovò
Volume: 3
Issue: 4
Year: 2011
Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen

Author(s): Paul H. Naylor | James E. Egan | Neil L. Berinstein
Volume: 3
Issue: 4
Year: 2011
Role of Radiation Therapy in the Management of Renal Cell Cancer

Author(s): Angel I. Blanco | Bin S. Teh | Robert J. Amato
Volume: 3
Issue: 4
Year: 2011
Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects

Author(s): Dhruba J. Bharali | Imtiaz A. Siddiqui | Vaqar M. Adhami | Jean Christopher Chamcheu | Abdullah M. Aldahmash | Hasan Mukhtar | Shaker A. Mousa
Volume: 3
Issue: 4
Year: 2011
Carbon Ion Radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-up

Author(s): Tatsuya Ohno | Tatsuaki Kanai | Satoru Yamada | Ken Yusa | Mutsumi Tashiro | Hirofumi Shimada | Kota Torikai | Yukari Yoshida | Yoko Kitada | Hiroyuki Katoh | Takayoshi Ishii | Takashi Nakano
Volume: 3
Issue: 4
Year: 2011
A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG)

Author(s): Maurizio Amichetti | Dante Amelio
Volume: 3
Issue: 4
Year: 2011
Discriminating Different Cancer Cells Using a Zebrafish in Vivo Assay

Author(s): Karni S. Moshal | Karine F. Ferri-Lagneau | Jamil Haider | Pooja Pardhanani | TinChung Leung
Volume: 3
Issue: 4
Year: 2011
Distribution of Functional Liver Volume in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus in the 1st Branch and Main Trunk Using Single Photon Emission Computed Tomography—Application to Radiation Therapy

Author(s): Shintaro Shirai | Morio Sato | Yasutaka Noda | Kazushi Kishi | Nobuyuki Kawai | Hiroki Minamiguchi | Motoki Nakai | Hiroki Sanda | Shinya Sahara | Akira Ikoma | Tetsuo Sonomura
Volume: 3
Issue: 4
Year: 2011
Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study

Author(s): Camilla T. Karlsson | Fredrik Wiklund | Henrik Grönberg | Anders Bergh | Beatrice Melin
Volume: 3
Issue: 4
Year: 2011
Sarcoma Immunotherapy

Author(s): Launce G. Gouw | Kevin B. Jones | Sunil Sharma | R. Lor Randall
Volume: 3
Issue: 4
Year: 2011
Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology

Author(s): Leah Hennings | Cecile Artaud | Fariba Jousheghany | Behjatolah Monzavi-Karbassi | Anastas Pashov | Thomas Kieber-Emmons
Volume: 3
Issue: 4
Year: 2011
Transcription Inhibition as a Therapeutic Target for Cancer

Author(s): Christine M. Stellrecht | Lisa S. Chen
Volume: 3
Issue: 4
Year: 2011
Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines

Author(s): Lijin Li | Peter Goedegebuure | Elaine R. Mardis | Matthew J.C. Ellis | Xiuli Zhang | John M. Herndon | Timothy P. Fleming | Beatriz M. Carreno | Ted H. Hansen | William E. Gillanders
Volume: 3
Issue: 4
Year: 2011
Immunohistochemical Assessment of Expression of Centromere Protein—A (CENPA) in Human Invasive Breast Cancer

Author(s): Ashish B. Rajput | Nianping Hu | Sonal Varma | Chien-Hung Chen | Keyue Ding | Paul C. Park | Judy-Anne W. Chapman | Sandip K. SenGupta | Yolanda Madarnas | Bruce E. Elliott | Harriet E. Feilotter
Volume: 3
Issue: 4
Year: 2011
A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90a

Author(s): Adi Mehta | Leroy Shervington | Chinmay Munje | Amal Shervington
Volume: 3
Issue: 4
Year: 2011
Stroma-Directed Molecular Targeted Therapy in Gastric Cancer

Author(s): Yasuhiko Kitadai | Michiyo Kodama | Kei Shinagawa
Volume: 3
Issue: 4
Year: 2011
NF-kappaB in Lung Tumorigenesis

Author(s): Zhenjian Cai | Kam-Meng Tchou-Wong | William N. Rom
Volume: 3
Issue: 4
Year: 2011
Clinical Investigation of the Role of Interleukin-4 and Interleukin-13 in the Evolution of Prostate Cancer

Author(s): Robert Goldstein | Charles Hanley | Jonathan Morris | Declan Cahill | Ashish Chandra | Peter Harper | Simon Chowdhury | John Maher | Sophie Burbridge
Volume: 3
Issue: 4
Year: 2011
Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice

Author(s): Laura P. Stabile | Mary E. Rothstein | Phouthone Keohavong | Diana Lenzner | Stephanie R. Land | Autumn L. Gaither-Davis | K. Jin Kim | Naftali Kaminski | Jill M. Siegfried
Volume: 2
Issue: 4
Year: 2010
Treatment of Brain Metastasis from Lung Cancer

Author(s): Alexander Chi | Ritsuko Komaki
Volume: 2
Issue: 4
Year: 2010
Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression

Author(s): Seth B. Krantz | Mario A. Shields | Surabhi Dangi-Garimella | David J. Bentrem | Hidayatullah G. Munshi
Volume: 2
Issue: 4
Year: 2010
The Enigmatic Roles of Caspases in Tumor Development

Author(s): Richard Jäger | Ralf M. Zwacka
Volume: 2
Issue: 4
Year: 2010
Epidemiology of Skin Cancer: Role of Some Environmental Factors

Author(s): Gabriella Fabbrocini | Maria Triassi | Maria Chiara Mauriello | Guglielma Torre | Maria Carmela Annunziata | Valerio De Vita | Francesco Pastore | Vincenza D’Arco | Giuseppe Monfrecola
Volume: 2
Issue: 4
Year: 2010
A Comparative Study of Two Folate-Conjugated Gold Nanoparticles for Cancer Nanotechnology Applications

Author(s): G. Ali Mansoori | Kenneth S. Brandenburg | Ali Shakeri-Zadeh
Volume: 2
Issue: 4
Year: 2010
NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells

Author(s): Nuno R. dos Santos | Marinella N. Ghezzo | Ricardo C. da Silva | Mónica T. Fernandes
Volume: 2
Issue: 4
Year: 2010
Lung Cancer Susceptibility and hOGG1 Ser326Cys Polymorphism: A Meta-Analysis

Author(s): Chikako Kiyohara | Koichi Takayama | Yoichi Nakanishi
Volume: 2
Issue: 4
Year: 2010
CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer

Author(s): Dorrah Deeb | Xiaohua Gao | Ali S. Arbab | Kenneth Barton | Scott A. Dulchavsky | Subhash C. Gautam
Volume: 2
Issue: 4
Year: 2010
Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness

Author(s): Sophie Vasseur | Richard Tomasini | Roselyne Tournaire | Juan L. Iovanna
Volume: 2
Issue: 4
Year: 2010
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma

Author(s): Harald J. Maier | Thomas Wirth | Hartmut Beug
Volume: 2
Issue: 4
Year: 2010
Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections

Author(s): Anna Melissa Schlitter | Irene Esposito
Volume: 2
Issue: 4
Year: 2010
Selection and Outcome of Portal Vein Resection in Pancreatic Cancer

Author(s): Akimasa Nakao
Volume: 2
Issue: 4
Year: 2010
Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer

Author(s): Laura Johnson | Geoff Charles-Edwards | Michael Douek
Volume: 2
Issue: 4
Year: 2010
Familial Pancreatic Cancer

Author(s): Henry T. Lynch | Jane F. Lynch | Stephen J. Lanspa
Volume: 2
Issue: 4
Year: 2010
Breast Cancer: Surgery at the South Egypt Cancer Institute

Author(s): Ahmed A.S. Salem | Mohamed Abou Elmagd Salem | Hamza Abbass
Volume: 2
Issue: 4
Year: 2010
Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

Author(s): Florian Ehehalt | Ellen Franke | Christian Pilarsky | Robert Grützmann
Volume: 2
Issue: 4
Year: 2010
Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management

Author(s): Maciej Salagierski | Marek S. Salagierski
Volume: 2
Issue: 4
Year: 2010
Mucins and Pancreatic Cancer

Author(s): Nicolas Jonckheere | Nicolas Skrypek | Isabelle Van Seuningen
Volume: 2
Issue: 4
Year: 2010
Does Ablation Technique Utilized in the Management of Unresectable Locally Advanced Pancreatic Adenocarcinoma?

Author(s): Raffaele Pezzilli | Dario Fabbri | Andrea Imbrogno
Volume: 2
Issue: 4
Year: 2010
A Distinct Slow-Cycling Cancer Stem-like Subpopulation of Pancreatic Adenocarcinoma Cells is maintained in Vivo

Author(s): Jennifer L. Dembinski | Stefan Krauss
Volume: 2
Issue: 4
Year: 2010
Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy

Author(s): Ludovic T. Nguyen | Socheat Touch | Hélène Nehme-Schuster | Delphine Antoni | Sokha Eav | Jean-Baptiste Clavier | Nicolas Bauer | Céline Vigneron | Roland Schott | Pierre Kehrli | Georges Noël
Volume: 5
Issue: 3
Year: 2013
Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose?

Author(s): Nicola Di Santo | Jessie Ehrisman
Volume: 5
Issue: 3
Year: 2013
Leptin’s Pro-Angiogenic Signature in Breast Cancer

Author(s): Ruben Rene Gonzalez-Perez | Viola Lanier | Gale Newman
Volume: 5
Issue: 3
Year: 2013
Emerging Biomarkers in Glioblastoma

Author(s): Mairéad G. McNamara | Solmaz Sahebjam | Warren P. Mason
Volume: 5
Issue: 3
Year: 2013
Control of Oxidative Stress and Generation of Induced Pluripotent Stem Cell-like Cells by Jun Dimerization Protein 2

Author(s): Shyh-Shin Chiou | Sophie Sheng-Wen Wang | Deng-Chyang Wu | Ying-Chu Lin | Li-Pin Kao | Kung-Kai Kuo | Chun-Chieh Wu | Chee-Yin Chai | Cheng-Lung Steve Lin | Cheng-Yi Lee | Yu-Mei Liao | Kenly Wuputra | Ya-Han Yang | Shin-Wei Wang | Chia-Chen Ku | Yukio Nakamura | Shigeo Saito | Hitomi Hasegawa | Naoto Yamaguchi | Hiroyuki Miyoshi | Chang-Sheng Lin | Richard Eckner | Kazunari K. Yokoyama
Volume: 5
Issue: 3
Year: 2013
PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?

Author(s): Amanda F. Swindall | Jennifer A. Stanley | Eddy S. Yang
Volume: 5
Issue: 3
Year: 2013
Immune Regulatory Activity of Vitamin D3 in Head and Neck Cancer

Author(s): M. Rita I. Young | Terry A. Day
Volume: 5
Issue: 3
Year: 2013
Glioblastoma-Initiating Cells: Relationship with Neural Stem Cells and the Micro-Environment

Author(s): Nicolas Goffart | Jérôme Kroonen | Bernard Rogister
Volume: 5
Issue: 3
Year: 2013
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Author(s): Matthias van Woensel | Nathalie Wauthoz | Rémi Rosière | Karim Amighi | Véronique Mathieu | Florence Lefranc | Stefaan W. van Gool | Steven de Vleeschouwer
Volume: 5
Issue: 3
Year: 2013
The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer

Author(s): Prashant Kumar Singh | Moray J. Campbell
Volume: 5
Issue: 3
Year: 2013
The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy

Author(s): Laura K. Green | Mathew A. Storey | Elsie M. Williams | Adam V. Patterson | Jeff B. Smaill | Janine N. Copp | David F. Ackerley
Volume: 5
Issue: 3
Year: 2013
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies

Author(s): Antonino Grassadonia | Pasquale Cioffi | Felice Simiele | Laura Iezzi | Marinella Zilli | Clara Natoli
Volume: 5
Issue: 3
Year: 2013
Characterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular Models

Author(s): Alessandro Natoni | Mark R. E. Coyne | Alan Jacobsen | Michael D. Rainey | Gemma O'Brien | Sandra Healy | Alessia Montagnoli | Jürgen Moll | Michael O'Dwyer | Corrado Santocanale
Volume: 5
Issue: 3
Year: 2013
Head and Neck Sarcomas: A Comprehensive Cancer Center Experience

Author(s): Mohamedtaki A. Tejani | Thomas J. Galloway | Miriam Lango | John A. Ridge | Margaret von Mehren
Volume: 5
Issue: 3
Year: 2013
Utility of MRI Diffusion Techniques in the Evaluation of Tumors of the Head and Neck

Author(s): José Pablo Martínez Barbero | Inmaculada Rodríquez Jiménez | Teodoro Martin Noguerol | Antonio Luna Alcalá
Volume: 5
Issue: 3
Year: 2013
Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications

Author(s): Therese Liechtenstein | Noemi Perez-Janices | David Escors
Volume: 5
Issue: 3
Year: 2013
Influence of Levamisole and Other Angiogenesis Inhibitors on Angiogenesis and Endothelial Cell Morphology in Vitro

Author(s): Tina Friis | Anne-Marie Engel | Christine D. Bendiksen | Line S. Larsen | Gunnar Houen
Volume: 5
Issue: 3
Year: 2013
Synthetic Genetic Targeting of Genome Instability in Cancer

Author(s): Babu V. Sajesh | Brent J. Guppy | Kirk J. McManus
Volume: 5
Issue: 3
Year: 2013
Alterations of 5-Hydroxymethylcytosine in Human Cancers

Author(s): Christopher J. Mariani | Jozef Madzo | Erika L. Moen | Ali Yesilkanal | Lucy A. Godley
Volume: 5
Issue: 3
Year: 2013
The Expression of Embryonic Liver Development Genes in Hepatitis C Induced Cirrhosis and Hepatocellular Carcinoma

Author(s): Martha Behnke | Mark Reimers | Robert Fisher
Volume: 4
Issue: 3
Year: 2012
Therapeutic Targeting of Hyaluronan in the Tumor Stroma

Author(s): Anne Kultti | Xiaoming Li | Ping Jiang | Curtis B. Thompson | Gregory I. Frost | H. Michael Shepard
Volume: 4
Issue: 3
Year: 2012
Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)

Author(s): Naz Chaudary | Melania Pintilie | Joerg Schwock | Neesha Dhani | Blaise Clarke | Michael Milosevic | Anthony Fyles | Richard P. Hill
Volume: 4
Issue: 3
Year: 2012
Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies

Author(s): Kentaro Nakayama | Naomi Nakayama | Masako Ishikawa | Kohji Miyazaki
Volume: 4
Issue: 3
Year: 2012
Succinate Dehydrogenase B Subunit Immunohistochemical Expression Predicts Aggressiveness in Well Differentiated Neuroendocrine Tumors of the Ileum

Author(s): Massimo Milione | Sara Pusceddu | Patrizia Gasparini | Flavia Melotti | Patrick Maisonneuve | Vincenzo Mazzaferro | Filippo G. de Braud | Giuseppe Pelosi
Volume: 4
Issue: 3
Year: 2012
Neuroendocrine Tumors of the Lung

Author(s): Annette Fisseler-Eckhoff | Melanie Demes
Volume: 4
Issue: 3
Year: 2012
A microRNA Link to Glioblastoma Heterogeneity

Author(s): Sanjay K. Singh | Alenoush Vartanian | Kelly Burrell | Gelareh Zadeh
Volume: 4
Issue: 3
Year: 2012
Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-α

Author(s): Leah A. Marquez-Curtis | Neeta Shirvaikar | A. Robert Turner | Imran Mirza | Amir Surmawala | Loree M. Larratt | Anna Janowska-Wieczorek
Volume: 4
Issue: 3
Year: 2012
Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological Characteristics

Author(s): Jamaica D. Cass | Sonal Varma | Andrew G. Day | Waheed Sangrar | Ashish B. Rajput | Leda H. Raptis | Jeremy Squire | Yolanda Madarnas | Sandip K. SenGupta | Bruce E. Elliott
Volume: 4
Issue: 3
Year: 2012
Ovarian Cancer Stroma: Pathophysiology and the Roles in Cancer Development

Author(s): Mitsuko Furuya
Volume: 4
Issue: 3
Year: 2012
Association of Differentiation-Related Gene-1 (DRG1) with Breast Cancer Survival and in Vitro Impact of DRG1 Suppression

Author(s): Ruqia Mehmood Baig | Andrew J. Sanders | Mahmood Akhtar Kayani | Wen G. Jiang
Volume: 4
Issue: 3
Year: 2012
Macrophage-Mediated Lymphangiogenesis: The Emerging Role of Macrophages as Lymphatic Endothelial Progenitors

Author(s): Sophia Ran | Kyle E. Montgomery
Volume: 4
Issue: 3
Year: 2012
Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer

Author(s): Naofumi Mukaida | So-ichiro Sasakki | Boryana K. Popivanova
Volume: 3
Issue: 3
Year: 2011
Extracellular NM23 Signaling in Breast Cancer: Incommodus Verum

Author(s): Iain L.O. Buxton | Nucharee Yokdang
Volume: 3
Issue: 3
Year: 2011
Prediction of Metastasis and Recurrence in Colorectal Cancer Based on Gene Expression Analysis: Ready for the Clinic?

Author(s): Masaki Shibayama | Matthias Maak | Ulrich Nitsche | Kengo Gotoh | Robert Rosenberg | Klaus-Peter Janssen
Volume: 3
Issue: 3
Year: 2011
Two Domains of Vimentin Are Expressed on the Surface of Lymph Node, Bone and Brain Metastatic Prostate Cancer Lines along with the Putative Stem Cell Marker Proteins CD44 and CD133

Author(s): Nicole F. Steinmetz | Jochen Maurer | Huiming Sheng | Armand Bensussan | Igor Maricic | Vipin Kumar | Todd A. Braciak
Volume: 3
Issue: 3
Year: 2011
Current Concepts of Metastasis Formation

Author(s): Jörg Haier | Peter Gassman
Volume: 3
Issue: 3
Year: 2011
Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications

Author(s): Shaker A. Mousa | Dhruba J. Bharali
Volume: 3
Issue: 3
Year: 2011
Immune Suppression in Tumors as a Surmountable Obstacle to Clinical Efficacy of Cancer Vaccines

Author(s): Grégoire Wieërs | Nathalie Demotte | Danièle Godelaine | Pierre Van der Bruggen
Volume: 3
Issue: 3
Year: 2011
Mechanisms and Therapeutic Implications of Cell Death Induction by Indole Compounds

Author(s): Aamir Ahmad | Wael A. Sakr | KM Wahidur Rahman
Volume: 3
Issue: 3
Year: 2011
Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise

Author(s): Connie E. Kim | Kam-Meng Tchou-Wong | William N. Rom
Volume: 3
Issue: 3
Year: 2011
β-Catenin Is a Positive Regulator of Estrogen Receptor-α Function in Breast Cancer Cells

Author(s): Nibedita Gupta | Fee Schmitt | Sina Grebhardt | Doris Mayer
Volume: 3
Issue: 3
Year: 2011
Evolution of Tumor Metabolism might Reflect Carcinogenesis as a Reverse Evolution process (Dismantling of Multicellularity)

Author(s): Khalid O. Alfarouk | Mohammed E.A. Shayoub | Abdel Khalig Muddathir | Gamal O. Elhassan | Adil H.H. Bashir
Volume: 3
Issue: 3
Year: 2011
Detouring the Undesired Route of Helicobacter pylori-Induced Gastric Carcinogenesis

Author(s): Eun-Hee Kim | Kyung-Sook Hong | Hua Hong | Ki Baik Hahm
Volume: 3
Issue: 3
Year: 2011
Dual Targeting of the Insulin-Like Growth Factor and Collateral Pathways in Cancer: Combating Drug Resistance

Author(s): Joseph A. Ludwig | Salah-Eddine Lamhamedi-Cherradi | Ho-Young Lee | Aung Naing | Robert Benjamin
Volume: 3
Issue: 3
Year: 2011
Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives

Author(s): Hiroshi Kitamura | Taiji Tsukamoto
Volume: 3
Issue: 3
Year: 2011
Natural and Induced Humoral Responses to MUC1

Author(s): Silvia Von Mensdorff-Pouilly | Maria Moreno | René H. M. Verheijen
Volume: 3
Issue: 3
Year: 2011
Inflammatory Alterations of the Extracellular Matrix in the Tumor Microenvironment

Author(s): Junko Iijima | Kenjiro Konno | Naoki Itano
Volume: 3
Issue: 3
Year: 2011
Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines

Author(s): Genevieve M. Weir | Robert S. Liwski | Marc Mansour
Volume: 3
Issue: 3
Year: 2011
Current Perspectives on Desmoid Tumors: The Mayo Clinic Approach

Author(s): Siddharth B. Joglekar | Peter S. Rose | Franklin Sim | Scott Okuno | Ivy Petersen
Volume: 3
Issue: 3
Year: 2011
Upregulation of Leukotriene Receptors in Gastric Cancer

Author(s): Marino Venerito | Doerthe Kuester | Caroline Harms | Daniel Schubert | Thomas Wex | Peter Malfertheiner
Volume: 3
Issue: 3
Year: 2011
C-type Lectin Receptors for Tumor Eradication: Future Directions

Author(s): Ingeborg Streng-Ouwehand | Wendy W. J. Unger | Yvette Van Kooyk
Volume: 3
Issue: 3
Year: 2011
Inflammation-Related Carcinogenesis and Prevention in Esophageal Adenocarcinoma Using Rat Duodenoesophageal Reflux Models

Author(s): Takashi Fujimura | Katsunobu Oyama | Shozo Sasaki | Koji Nishijima | Tomoharu Miyashita | Tetsuo Ohta | Koichi Miwa | Takanori Hattori
Volume: 3
Issue: 3
Year: 2011
Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

Author(s): Elena Quaglino | Federica Riccardo | Marco Macagno | Silvio Bandini | Rodica Cojoca | Elisabetta Ercole | Augusto Amici | Federica Cavallo
Volume: 3
Issue: 3
Year: 2011
Aberrant Signaling Pathways in Glioma

Author(s): Mitsutoshi Nakada | Daisuke Kita | Takuya Watanabe | Yutaka Hayashi | Lei Teng | Ilya V. Pyko | Jun-Ichiro Hamada
Volume: 3
Issue: 3
Year: 2011
Assessment of the Evolution of Cancer Treatment Therapies

Author(s): Manuel Arruebo | Nuria Vilaboa | Berta Sáez-Gutierrez | Julio Lambea | Alejandro Tres | Mónica Valladares | África González-Fernández
Volume: 3
Issue: 3
Year: 2011
Therapeutic Approaches to Target Cancer Stem Cells

Author(s): Arlhee Diaz | Kalet Leon
Volume: 3
Issue: 3
Year: 2011
Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer

Author(s): Xiaohua Gao | Dorrah Deeb | Yongbo Liu | Ali S. Arbab | George W. Divine | Scott A. Dulchavsky | Subhash C. Gautam
Volume: 3
Issue: 3
Year: 2011
Novel Antibody-Based Proteins for Cancer Immunotherapy

Author(s): Jaheli Fuenmayor | Ramon F. Montaño
Volume: 3
Issue: 3
Year: 2011
Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy

Author(s): Corey Montgomery | Cynthia Emory | Sheila Adams | Jonathan Cohen | John David Pitcher | Benjamin Kyle Potter | H. Thomas Temple
Volume: 3
Issue: 3
Year: 2011
Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer

Author(s): Robert J. Amato | L. Michael Glode | Jeremy Podolnick | Robert Knight | David Crawford
Volume: 3
Issue: 3
Year: 2011
New Approaches to Immunotherapy for HPV Associated Cancers

Author(s): Anne-Sophie Bergot | Andrew Kassianos | Ian H Frazer | Deepak Mittal
Volume: 3
Issue: 3
Year: 2011
Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre

Author(s): Joseph Sia | Daryl Lim Joon | Angela Viotto | Carmel Mantle | George Quong | Aldo Rolfo | Morikatsu Wada | Nigel Anderson | Maureen Rolfo | Vincent Khoo
Volume: 3
Issue: 3
Year: 2011
Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team

Author(s): Shervin M. Shirvani | Joe Y. Chang
Volume: 3
Issue: 3
Year: 2011
Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer

Author(s): Akira Tsuzuki | Yasuhiro Ogawa | Kei Kubota | Shiho Tokuhiro | Ryo Akima | Shin Yaogawa | Kenji Itoh | Yoko Yamada | Toshikazu Sasaki | Masahide Onogawa | Tomoaki Yamanishi | Shinji Kariya | Munenobu Nogami | Akihito Nishioka | Mitsuhiko Miyamura
Volume: 3
Issue: 3
Year: 2011
Epigenetics, Nervous System Tumors, and Cancer Stem Cells

Author(s): Irfan A. Qureshi | Mark F. Mehler
Volume: 3
Issue: 3
Year: 2011
Distinct Redox Profiles of Selected Human Prostate Carcinoma Cell Lines: Implications for Rational Design of Redox Therapy

Author(s): Luksana Chaiswing | Weixiong Zhong | Terry D. Oberley
Volume: 3
Issue: 3
Year: 2011
Efficacy and Safety of High-Dose-Rate Brachytherapy of Single Implant with Two Fractions Combined with External Beam Radiotherapy for Hormone-Naïve Localized Prostate Cancer

Author(s): Yasutaka Noda | Morio Sato | Shintaro Shirai | Kazushi Kishi | Takeshi Inagaki | Takeshi Mori | Isao Hara
Volume: 3
Issue: 3
Year: 2011
Type I Collagen Synthesis Marker Procollagen I N-Terminal Peptide (PINP) in Prostate Cancer Patients Undergoing Intermittent Androgen Suppression

Author(s): Gerhard Hamilton | Ulrike Olszewski-Hamilton | Gerhard Theyer
Volume: 3
Issue: 3
Year: 2011
Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy

Author(s): Chan Joo Yeom | Lihua Zeng | Yuxi Zhu | Masahiro Hiraoka | Hiroshi Harada
Volume: 3
Issue: 3
Year: 2011
Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy

Author(s): Michael Nowak | Ingo G.H. Schmidt-Wolf
Volume: 3
Issue: 3
Year: 2011
The Many Faces of Wnt and Pancreatic Ductal Adenocarcinoma Oncogenesis

Author(s): Colin D. Weekes | Robert A. Winn
Volume: 3
Issue: 3
Year: 2011
Emerging Cancer Vaccines: The Promise of Genetic Vectors

Author(s): Luigi Aurisicchio | Gennaro Ciliberto
Volume: 3
Issue: 3
Year: 2011
Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis

Author(s): Erica Ballabio | Thomas A. Milne
Volume: 4
Issue: 3
Year: 2012
Interaction of Stellate Cells with Pancreatic Carcinoma Cells

Author(s): Hansjörg Habisch | Shaoxia Zhou | Marco Siech | Max G. Bachem
Volume: 2
Issue: 3
Year: 2010
The Clinical Significance of Unknown Sequence Variants in BRCA Genes

Author(s): Valentina Calò | Loredana Bruno | Laura La Paglia | Marco Perez | Naomi Margarese | Francesca Di Gaudio | Antonio Russo
Volume: 2
Issue: 3
Year: 2010
DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes

Author(s): Dandan Niu | Huixing Feng | Wei Ning Chen
Volume: 2
Issue: 3
Year: 2010
5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs

Author(s): Koh Miura | Makoto Kinouchi | Kazuyuki Ishida | Wataru Fujibuchi | Takeshi Naitoh | Hitoshi Ogawa | Toshinori Ando | Nobuki Yazaki | Kazuhiro Watanabe | Sho Haneda | Chikashi Shibata | Iwao Sasaki
Volume: 2
Issue: 3
Year: 2010
The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology

Author(s): Alberto M. Martelli | Camilla Evangelisti | Francesca Chiarini | Cecilia Grimaldi | James A. McCubrey
Volume: 2
Issue: 3
Year: 2010
Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry

Author(s): Wen-Jing Wang | Wang-Hong Xu | Cha-Zhen Liu | Asif Rashid | Jia-Rong Cheng | Ping Liao | Heng Hu | Lisa W. Chu | Yu-Tang Gao | Kai Yu | Ann W. Hsing
Volume: 2
Issue: 3
Year: 2010
ZEB1 in Pancreatic Cancer

Author(s): Ulrich Wellner | Thomas Brabletz | Tobias Keck
Volume: 2
Issue: 3
Year: 2010
The Changing Face of Esophageal Cancer

Author(s): Rachel E. Melhado | Derek Alderson | Olga Tucker
Volume: 2
Issue: 3
Year: 2010
The Prognostic Value of Haplotypes in the Vascular Endothelial Growth Factor A Gene in Colorectal Cancer

Author(s): Torben F. Hansen | Karen-Lise G. Spindler | Rikke F. Andersen | Jan Lindebjerg | Steen Kølvraa | Ivan Brandslund | Anders Jakobsen
Volume: 2
Issue: 3
Year: 2010
The Problems of Radiofrequency Ablation as an Approach for Advanced Unresectable Ductal Pancreatic Carcinoma

Author(s): Raffaele Pezzilli | Claudio Ricci | Carla Serra | Riccardo Casadei | Francesco Monari | Marielda D’Ambra | Roberto Corinaldesi | Francesco Minni
Volume: 2
Issue: 3
Year: 2010
PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis

Author(s): Maciej Salagierski | Jack A. Schalken
Volume: 2
Issue: 3
Year: 2010
YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

Author(s): Nicolai A. Schultz | Julia S. Johansen
Volume: 2
Issue: 3
Year: 2010
The Kinase Mirk/dyrk1B: A Possible Therapeutic Target in Pancreatic Cancer

Author(s): Eileen Friedman
Volume: 2
Issue: 3
Year: 2010
Epigenetic Therapy in Human Choriocarcinoma

Author(s): Noriyuki Takai | Hisashi Narahara
Volume: 2
Issue: 3
Year: 2010
Aberrant Crypt Foci: The Case for Inclusion as a Biomarker for Colon Cancer

Author(s): Michael J. Wargovich | Vondina R. Brown | Jay Morris
Volume: 2
Issue: 3
Year: 2010
Cancer Stem Cells in Pancreatic Cancer

Author(s): Qi Bao | Yue Zhao | Andrea Renner | Hanno Niess | Hendrik Seeliger | Karl-Walter Jauch | Christiane J. Bruns
Volume: 2
Issue: 3
Year: 2010
Dermoscopy of Scalp Melanoma: Report of Three Cases

Author(s): Fernanda Torres | Gabriella Fabbrocini | Sergio Henrique Hirata | Sergio Yamada | Valerio De Vita | Maria Carmela Annunziata | Antonella Tosti
Volume: 2
Issue: 3
Year: 2010
A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment

Author(s): Chao Chen | Beate Köberle | Andreas M. Kaufmann | Andreas E. Albers
Volume: 2
Issue: 3
Year: 2010
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma

Author(s): Michael C. Stauder | Robert C. Miller
Volume: 2
Issue: 3
Year: 2010
Models of Hepatocellular Carcinoma and Biomarker Strategy

Author(s): Cedo M. Bagi | Catharine J. Andresen
Volume: 2
Issue: 3
Year: 2010
Bioelectric Applications for Treatment of Melanoma

Author(s): Stephen J. Beebe | Karl H. Schoenbach | Richard Heller
Volume: 2
Issue: 3
Year: 2010
Neural Invasion in Pancreatic Cancer: The Past, Present and Future

Author(s): Ihsan Ekin Demir | Güralp O. Ceyhan | Florian Liebl | Jan G. D’Haese | Matthias Maak | Helmut Friess
Volume: 2
Issue: 3
Year: 2010
Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse

Author(s): Aurelia Nguyen | Christelle Lasthaus | Eric Guerin | Luc Marcellin | Erwan Pencreach | Marie-Pierre Gaub | Dominique Guenot | Natacha Entz-Werle
Volume: 5
Issue: 2
Year: 2013
Effects of Ellagic Acid on Angiogenic Factors in Prostate Cancer Cells

Author(s): Luca Vanella | Claudia Di Giacomo | Rosaria Acquaviva | Ignazio Barbagallo | Giovanni Li Volti | Venera Cardile | Nader G. Abraham | Valeria Sorrenti
Volume: 5
Issue: 2
Year: 2013
Epigenetics and Colorectal Cancer Pathogenesis

Author(s): Kankana Bardhan | Kebin Liu
Volume: 5
Issue: 2
Year: 2013
Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin’s Lymphoma

Author(s): Hans Knecht | Christiaan Righolt | Sabine Mai
Volume: 5
Issue: 2
Year: 2013
Ras and Rheb Signaling in Survival and Cell Death

Author(s): Anja Ehrkamp | Christian Herrmann | Raphael Stoll | Rolf Heumann
Volume: 5
Issue: 2
Year: 2013
Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells

Author(s): Aditi Gupta | Cindy Q. Zhou | Meenakshi A. Chellaiah
Volume: 5
Issue: 2
Year: 2013
Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

Author(s): Kosei Ando | Marie-Françoise Heymann | Verena Stresing | Kanji Mori | Françoise Rédini | Dominique Heymann
Volume: 5
Issue: 2
Year: 2013
Immunotherapy and Immune Evasion in Prostate Cancer

Author(s): Archana Thakur | Ulka Vaishampayan | Lawrence G. Lum
Volume: 5
Issue: 2
Year: 2013
99mTc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies

Author(s): Frédéric L.W.V.J. Schaper | Chris P. Reutelingsperger
Volume: 5
Issue: 2
Year: 2013
Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results

Author(s): William W. Tseng | Neeta Somaiah | Alexander J. Lazar | Dina C. Lev | Raphael E. Pollock
Volume: 5
Issue: 2
Year: 2013
Lost in Translation: Ambiguity in Nerve Sheath Tumor Nomenclature and Its Resultant Treatment Effect

Author(s): Nicholas M. Bernthal | Kevin B. Jones | Michael J. Monument | Ting Liu | David Viskochil | R. Lor Randall
Volume: 5
Issue: 2
Year: 2013
The Lack of Predictors for Rapid Progression in Prostate Cancer Patients Receiving Sipuleucel-T

Author(s): Laura Ng | Wendy Heck | Stacey Lavsa | David Crowther | Brad Atkinson | Lianchun Xiao | John Araujo
Volume: 5
Issue: 2
Year: 2013
Regulatory Roles for Long ncRNA and mRNA

Author(s): Armen R. Karapetyan | Coen Buiting | Renske A. Kuiper | Marcel W. Coolen
Volume: 5
Issue: 2
Year: 2013
A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma

Author(s): Claire F. Verschraegen | Sujana Movva | Yongli Ji | Berndt Schmit | Robert H. Quinn | Ben Liem | Therese Bocklage | Monte Shaheen
Volume: 5
Issue: 2
Year: 2013
Ex Vivo Behaviour of Human Bone Tumor Endothelial Cells

Author(s): Teresa Infante | Elena Cesario | Michele Gallo | Flavio Fazioli | Annarosaria De Chiara | Cristina Tutucci | Gaetano Apice | Filomena de Nigris
Volume: 5
Issue: 2
Year: 2013
Protein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis

Author(s): Atta Goudarzi | Nalan Gokgoz | Mona Gill | Dushanthi Pinnaduwage | Daniele Merico | Jay S. Wunder | Irene L. Andrulis
Volume: 5
Issue: 2
Year: 2013
Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research

Author(s): Bryan W. Day | Brett W. Stringer | John Wilson | Rosalind L. Jeffree | Paul R. Jamieson | Kathleen S. Ensbey | Zara C. Bruce | Po Inglis | Suzanne Allan | Craig Winter | Gert Tollesson | Scott Campbell | Peter Lucas | Wendy Findlay | David Kadrian | David Johnson | Thomas Robertson | Terrance G. Johns | Perry F. Bartlett | Geoffrey W. Osborne | Andrew W. Boyd
Volume: 5
Issue: 2
Year: 2013
Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells

Author(s): Joëlle Roche | Patrick Nasarre | Robert Gemmill | Aleksander Baldys | Julien Pontis | Christopher Korch | Joëlle Guilhot | Slimane Ait-Si-Ali | Harry Drabkin
Volume: 5
Issue: 2
Year: 2013
Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy

Author(s): Anthony Park | Chindu Govindaraj | Sue D. Xiang | Julene Halo | Michael Quinn | Karen Scalzo-Inguanti | Magdalena Plebanski
Volume: 4
Issue: 2
Year: 2012
An Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications

Author(s): X. Sharon Qi | Qiuhui Yang | Steve P. Lee | X. Allen Li | Dian Wang
Volume: 4
Issue: 2
Year: 2012
Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials

Author(s): Massimo Di Maio | Gennaro Daniele | Maria Carmela Piccirillo | Pasqualina Giordano | Giuseppe Signoriello | Bruno Daniele | Francesco Perrone
Volume: 4
Issue: 2
Year: 2012
The Stroma—A Key Regulator in Prostate Function and Malignancy

Author(s): Christina Hägglöf | Anders Bergh
Volume: 4
Issue: 2
Year: 2012
T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma

Author(s): Oliver Abschuetz | Wolfram Osen | Kathrin Frank | Masashi Kato | Dirk Schadendorf | Viktor Umansky
Volume: 4
Issue: 2
Year: 2012
Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma

Author(s): Andrej Pala | Georg Karpel-Massler | Richard Eric Kast | Christian Rainer Wirtz | Marc-Eric Halatsch
Volume: 4
Issue: 2
Year: 2012
Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1

Author(s): Francesco Tonelli | Francesco Giudici | Francesca Giusti | Maria Luisa Brandi
Volume: 4
Issue: 2
Year: 2012
T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma

Author(s): Oliver Abschuetz | Wolfram Osen | Kathrin Frank | Masashi Kato | Dirk Schadendorf | Viktor Umansky
Volume: 4
Issue: 2
Year: 2012
Radical Decisions in Cancer: Redox Control of Cell Growth and Death

Author(s): Rosa M. Sainz | Felipe Lombo | Juan C. Mayo
Volume: 4
Issue: 2
Year: 2012
P190B RhoGAP Regulates Chromosome Segregation in Cancer Cells

Author(s): Melissa Hwang | Sirisha Peddibhotla | Peter McHenry | Peggy Chang | Zachary Yochum | Ko Un Park | James Cooper Sears | Tracy Vargo-Gogola
Volume: 4
Issue: 2
Year: 2012
Immune Response to Sipuleucel-T in Prostate Cancer

Author(s): Eddie Thara | Tanya B. Dorff | Monica Averia-Suboc | Michael Luther | Mary E. Reed | Jacek K. Pinski | David I. Quinn
Volume: 4
Issue: 2
Year: 2012
The Dynamics of Developmental and Tumor Angiogenesis—A Comparison

Author(s): Yi Jin | Lars Jakobsson
Volume: 4
Issue: 2
Year: 2012
A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase

Author(s): Venturina Stagni | Simonetta Santini | Daniela Barilà
Volume: 4
Issue: 2
Year: 2012
External Beam Radiotherapy of Recurrent Glioma: Radiation Tolerance of the Human Brain

Author(s): Peter Sminia | Ramona Mayer
Volume: 4
Issue: 2
Year: 2012
Remodeling of Tumor Stroma and Response to Therapy

Author(s): Anna Johansson | Ruth Ganss
Volume: 4
Issue: 2
Year: 2012
Micronutrient Synergy in the Fight against Hepatocellular Carcinoma

Author(s): M. Waheed Roomi | Nusrath W. Roomi | Tatiana Kalinovsky | Aleksandra Niedzwiecki | Matthias Rath
Volume: 4
Issue: 2
Year: 2012
Cell Death Pathways in Photodynamic Therapy of Cancer

Author(s): Pawel Mroz | Anastasia Yaroslavsky | Gitika B Kharkwal | Michael R. Hamblin
Volume: 3
Issue: 2
Year: 2011
Tumor Cell Seeding During Surgery—Possible Contribution to Metastasis Formations

Author(s): Pachmann Katharina
Volume: 3
Issue: 2
Year: 2011
State of the Art in Tumor Antigen and Biomarker Discovery

Author(s): Klervi Even-Desrumeaux | Daniel Baty | Patrick Chames
Volume: 3
Issue: 2
Year: 2011
Enhancing Photodynamyc Therapy Efficacy by Combination Therapy: Dated, Current and Oncoming Strategies

Author(s): Ilaria Postiglione | Angela Chiaviello | Giuseppe Palumbo
Volume: 3
Issue: 2
Year: 2011
Regulation of Autophagy by Kinases

Author(s): Savitha Sridharan | Kirti Jain | Alakananda Basu
Volume: 3
Issue: 2
Year: 2011
Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications

Author(s): Demirkan B. Gürsel | Benjamin J. Shin | Jan-Karl Burkhardt | Kartik Kesavabhotla | Cody D. Schlaff | John A. Boockvar
Volume: 3
Issue: 2
Year: 2011
Clinical Trial Design for Testing the Stem Cell Model for the Prevention and Treatment of Cancer

Author(s): Rishindra M. Reddy | Madhuri Kakarala | Max S. Wicha
Volume: 3
Issue: 2
Year: 2011
TRAF4, at the Crossroad between Morphogenesis and Cancer

Author(s): Adrien Rousseau | Marie-Christine Rio | Fabien Alpy
Volume: 3
Issue: 2
Year: 2011
Metastasizing, Luciferase Transduced MAT‑Lu Rat Prostate Cancer Models: Follow up of Bolus and Metronomic Therapy with Doxorubicin as Model Drug

Author(s): Peter Jantscheff | Norbert Esser | Andreas Geipel | Peter Woias | Vittorio Ziroli | Frank Goldschmidtboing | Ulrich Massing
Volume: 3
Issue: 2
Year: 2011
Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis

Author(s): Atsushi Takai | Hiroyuki Marusawa | Tsutomu Chiba
Volume: 3
Issue: 2
Year: 2011
Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer

Author(s): Ola Marzouk | John Schofield
Volume: 3
Issue: 2
Year: 2011
Comparison of Dose Response Models for Predicting Normal Tissue Complications from Cancer Radiotherapy: Application in Rat Spinal Cord

Author(s): Magdalena Adamus-Górka | Panayiotis Mavroidis | Bengt K. Lind | Anders Brahme
Volume: 3
Issue: 2
Year: 2011
Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer

Author(s): Carmen Berasain | María Ujue Latasa | Raquel Urtasun | Saioa Goñi | María Elizalde | Oihane Garcia-Irigoyen | María Azcona | Jesús Prieto | Matías A. Ávila
Volume: 3
Issue: 2
Year: 2011
Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer

Author(s): Michio Abe | Zbigniew P. Kortylewicz | Charles A. Enke | Elizabeth Mack | Janina Baranowska-Kortylewicz
Volume: 3
Issue: 2
Year: 2011
Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

Author(s): Marc Dufour | Anne Dormond-Meuwly | Nicolas Demartines | Olivier Dormond
Volume: 3
Issue: 2
Year: 2011
Differentiation Therapy of Acute Myeloid Leukemia

Author(s): Elzbieta Gocek | Ewa Marcinkowska
Volume: 3
Issue: 2
Year: 2011
Systematic Review of Breast Cancer Biology in Developing Countries (Part 1): Africa, the Middle East, Eastern Europe, Mexico, the Caribbean and South America

Author(s): Riyaz Bhikoo | Sanket Srinivasa | Tzu-Chieh Yu | David Moss | Andrew G Hill
Volume: 3
Issue: 2
Year: 2011
Systematic Review of Breast Cancer Biology in Developing Countries (Part 2): Asian Subcontinent and South East Asia

Author(s): Riyaz Bhikoo | Sanket Srinivasa | Tzu-Chieh Yu | David Moss | Andrew G Hill
Volume: 3
Issue: 2
Year: 2011
Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?

Author(s): Carolin Zimmermann | Gunnar Folprecht | Daniel Zips | Christian Pilarsky | Hans Detlev Saeger | Robert Grutzmann
Volume: 3
Issue: 2
Year: 2011
The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis Paper

Author(s): Irene Grossmann | Charlotte Verberne | Geertruida de Bock | Klaas Havenga | Ido Kema | Joost Klaase | Andrew Renehan | Theo Wiggers
Volume: 3
Issue: 2
Year: 2011
Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors

Author(s): Annika Waldmann | Sandra Nolte | Ron Pritzkuleit | Eckhard W. Breitbart | Alexander Katalinic
Volume: 3
Issue: 2
Year: 2011
Tomato Lycopene and Lung Cancer Prevention: From Experimental to Human Studies

Author(s): Paola Palozza | Rossella E. Simone | Assunta Catalano | Maria Cristina Mele
Volume: 3
Issue: 2
Year: 2011
Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro

Author(s): Wei Xu | Bisrat G. Debeb | Lara Lacerda | Jessica Li | Wendy A. Woodward
Volume: 3
Issue: 2
Year: 2011
Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy

Author(s): Kenichiro Hasumi | Yukimasa Aoki | Ryuko Watanabe | Kim G. Hankey | Dean L. Mann
Volume: 3
Issue: 2
Year: 2011
Targeted Therapy for Biliary Tract Cancer

Author(s): Junji Furuse | Takuji Okusaka
Volume: 3
Issue: 2
Year: 2011
Inferences for the Lead Time in Breast Cancer Screening Trials under a Stable Disease Model

Author(s): Justin Shows | Dongfeng Wu
Volume: 3
Issue: 2
Year: 2011
Lymph Node Metastasis of Gastric Cancer

Author(s): Tomonori Akagi | Norio Shiraishi | Seigo Kitano
Volume: 3
Issue: 2
Year: 2011
The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis

Author(s): John Conti | Gareth Thomas
Volume: 3
Issue: 2
Year: 2011
Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy

Author(s): Gaya Spolverato | Salvatore Pucciarelli | Roberta Bertorelle | Anita De Rossi | Donato Nitti
Volume: 3
Issue: 2
Year: 2011
Essential Gene Pathways for Glioblastoma Stem Cells: Clinical Implications for Prevention of Tumor Recurrence

Author(s): Kazunari Yamada | Jonathan Tso | Fei Ye | Jinny Choe | Yue Liu | Linda M. Liau | Cho-Lea Tso
Volume: 3
Issue: 2
Year: 2011
Common Altered Epigenomic Domains in Cancer Cells: Characterization and Subtle Variations

Author(s): Yi-Chien Tsai | Chun-Hui Chiao | Ian Yi-Feng Chang | Dow-Tien Chen | Tze-Tze Liu | Kate Hua | Chuan-Hsiung Chang | Ming-Ta Hsu
Volume: 3
Issue: 2
Year: 2011
EGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab’s Clinical Effects

Author(s): Rolando Perez | Ernesto Moreno | Greta Garrido | Tania Crombet
Volume: 3
Issue: 2
Year: 2011
Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation

Author(s): Susie I. Ymer | Sameer A. Greenall | Anna Cvrljevic | Diana X. Cao | Jacqui F. Donoghue | V. Chandana Epa | Andrew M. Scott | Timothy E. Adams | Terrance G. Johns
Volume: 3
Issue: 2
Year: 2011
Prognostic Value of Colorectal Cancer Biomarkers

Author(s): Paolo Bianchi | Luigi Laghi | Gabriele Delconte | Alberto Malesci
Volume: 3
Issue: 2
Year: 2011
Cancer Stem Cells and Side Population Cells in Breast Cancer and Metastasis

Author(s): Kelly M. Britton | John A. Kirby | Thomas W.J. Lennard | Annette P. Meeson
Volume: 3
Issue: 2
Year: 2011
Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown

Author(s): Simone Di Franco | Pietro Mancuso | Antonina Benfante | Marisa Spina | Flora Iovino | Francesco Dieli | Giorgio Stassi | Matilde Todaro
Volume: 3
Issue: 2
Year: 2011
Neuropilins: A New Target for Cancer Therapy

Author(s): Camille Grandclement | Christophe Borg
Volume: 3
Issue: 2
Year: 2011
Targeted Alpha Therapy Approach to the Management of Pancreatic Cancer

Author(s): Barry J. Allen | Syed M. Abbas Rizvi | Chang F. Qu | Ross C. Smith
Volume: 3
Issue: 2
Year: 2011
Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice

Author(s): Charlotte Lemech | Hendrik-Tobias Arkenau
Volume: 3
Issue: 2
Year: 2011
Molecular Epidemiology of Female Lung Cancer

Author(s): Seon-Hee Yim | Yeun-Jun Chung
Volume: 3
Issue: 2
Year: 2011
Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer

Author(s): Kang Mei Chen | Josena K. Stephen | Usha Raju | Maria J. Worsham
Volume: 3
Issue: 2
Year: 2011
Role of Surgery in Stages II and III Pediatric Abdominal Non-Hodgkin Lymphoma: A 5-Years Experience

Author(s): Amany M. Ali | Heba A. Sayd | Hesham M. Hamza | Mohamed A. Salem
Volume: 3
Issue: 2
Year: 2011
The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells

Author(s): Stuart A. Rushworth | David J. MacEwan
Volume: 3
Issue: 2
Year: 2011
Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy

Author(s): Ahmad R. Safa | Karen E. Pollok
Volume: 3
Issue: 2
Year: 2011
Role of Gene Methylation in Antitumor Immune Response: Implication for Tumor Progression

Author(s): Alfonso Serrano | Isabel Castro-Vega | Maximino Redondo
Volume: 3
Issue: 2
Year: 2011
Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy

Author(s): Monica Mann | Valerie Cortez | Ratna K. Vadlamudi
Volume: 3
Issue: 2
Year: 2011
Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance

Author(s): Dimitrios Mougiakakos
Volume: 3
Issue: 2
Year: 2011
To Die or to Survive, a Fatal Question for the Destiny of Prostate Cancer Cells after Androgen Deprivation Therapy

Author(s): Kai-Xin Zhang | Jessica Firus | Brenda Prieur | William Jia | Paul S. Rennie
Volume: 3
Issue: 2
Year: 2011
Epidermal Growth Factor Receptor in Pancreatic Cancer

Author(s): Melissa Oliveira-Cunha | William G. Newman | Ajith K. Siriwardena
Volume: 3
Issue: 2
Year: 2011
Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy

Author(s): Ashiq Masood | Asfar S. Azmi | Ramzi M. Mohammad
Volume: 3
Issue: 2
Year: 2011
Epigenetic Regulation of Glucose Transporters in Non-Small Cell Lung Cancer

Author(s): Kenneth J. O'Byrne | Anne-Marie Baird | Lisa Kilmartin | Jennifer Leonard | Calen Sacevich | Steven G. Gray
Volume: 3
Issue: 2
Year: 2011
In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal Glycolipids

Author(s): Uri Galili | Mark R. Albertini | Paul M. Sondel | Kim Wigglesworth | Mary Sullivan | Giles F. Whalen
Volume: 2
Issue: 2
Year: 2010
Surgery of Primary Melanomas

Author(s): Piotr Rutkowski | Marcin Zdzienicki | Zbigniew I. Nowecki | Alexander C. J. van Akkooi
Volume: 2
Issue: 2
Year: 2010
Role of Oxidative Stress in Stem, Cancer, and Cancer Stem Cells

Author(s): Ahmed Abdal Dayem | Hye-Yeon Choi | Jung-Hyun Kim | Ssang-Goo Cho
Volume: 2
Issue: 2
Year: 2010
The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature

Author(s): Raymon H. Grogan | Elliot J. Mitmaker | Orlo H. Clark
Volume: 2
Issue: 2
Year: 2010
Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies

Author(s): Cécile Le Page | David G. Huntsman | Diane M. Provencher | Anne-Marie Mes-Masson
Volume: 2
Issue: 2
Year: 2010
VEGF and Pleiotrophin Modulate the Immune Profile of Breast Cancer

Author(s): Kristi D. Lynn | Christina L. Roland | Rolf A. Brekken
Volume: 2
Issue: 2
Year: 2010
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress

Author(s): Paola Massi | Marta Valenti | Marta Solinas | Daniela Parolaro
Volume: 2
Issue: 2
Year: 2010
Blood-Based Biomarkers for the Optimization of Anti-Angiogenic Therapies

Author(s): Cristina Rabascio | Francesco Bertolini
Volume: 2
Issue: 2
Year: 2010
Why do you need a reservation system?      Affiliate Program